Alzheimer’s sufferers have lower plasmalogen levels than healthy people. Plasmalogen is a phospholipid essential to brain, lung, and heart function. Neuro-biochemical researcher Dr. Dayan Goodenowe identifies low plasmalogen as the cause of Alzheimer’s disease.
What happens when plasmalogen levels are restored in dementia and Alzheimer’s dementia sufferers?
On Vital Signs, host Brendon Fallon presents stories of people with severe dementia now receiving Dr. Goodenowe’s plasmalogen treatment, along with other essential nutrients. These patients include Carolyn, in her 70s and Helen, who's in her 80s. Both women have suffered a severe loss of mobility and cognition, including the ability to communicate, through dementia.
In 2007, Dr. Goodenowe patented a mass-spectrometry technology that identified low plasmalogen levels in the blood of Alzheimer’s sufferers. The results he has seen in restoring plasmalogen to Alzheimer’s patients support his conviction that low plasmalogen is the essential cause of Alzheimer’s.
The benefits of plasmalogen restoration relate to how our neurons (nerve cells) connect and transmit information to each other, as Dr. Goodowe explains:
“The fundamental operating system of the brain is synaptic transmission, fueled by vesicular release of neurotransmitters. That is ground zero of all human neurological function.”
And, he says, "that vesicular transport process is entirely dependent on plamalogen levels in the synapse.”
How are the faculties of memory and cognition created in the brain? What shuts those nerve connections down? And how does plasmalogen restoration work bring them back online?
⭕️ Watch in-depth videos based on Truth & Tradition at Epoch TV 👉 https://www.epochtv.com/
💛 Support us to fight for the truth! 👉 https://donorbox.org/epochtv